Webcast Synergistic Integration of Liposomes in Semi-Solid Formulations

Synergistic Integration of Liposomes in Semi-Solid Formulations

 · America/New_York

About This Webcast

This webinar will cover the intricacies of liposomal topical semi-solid products, focusing on their role in enhancing drug delivery through the skin. It will begin with an overview of semi-solid dosage forms, explaining their complex two-phase structure and how liposomes integrate into these formulations. Key topics will include skin anatomy, drug penetration pathways, and how liposomes improve dermato-pharmacokinetics compared to conventional semi-solid formulations. The session will also explore factors affecting drug release from liposome-based formulations, the influence of flux on skin permeation, and the benefits and challenges of developing these advanced delivery systems.

Speakers

Chetan Chure

Chetan Chure

Associate Director, Formulation Development , Contract Pharmaceuticals Limited (CPL)

Chetan Chure is the Associate Director of Formulation Development at CPL, bringing over 17 years of experience in developing both conventional and complex dosage forms, including topicals and liquid orals. Before joining CPL, Chetan held significant positions at Zydus Cadila and Glenmark Pharmaceuticals. He earned his Master of Pharmacy from the Birla Institute of Technology and Science, Pilani. Chetan's work has led to the approval of New Drug Applications and Abbreviated New Drug Applications, as well as several patents and publications.

Dr. David Osborne

Dr. David Osborne

President , David W Osborne PhD Consulting

Dr. David Osborne is a distinguished expert in topical drug formulation with a career spanning over three decades in dermatology and pharmaceutical sciences. He co-founded Arcutis Biotherapeutics, Inc. in 2016, where he served as Chief Technical Officer, contributing significantly to the development of innovative dermatological therapies. Throughout his career, Dr. Osborne has been instrumental in the development of numerous FDA-approved topical treatments, demonstrating a commitment to advancing therapeutic options for chronic skin conditions. His innovative approaches have addressed significant unmet needs in dermatology, particularly in creating non-steroidal therapies suitable for long-term use. Dr. Osborne's contributions have not only advanced the field of dermatology but also improved the quality of life for countless individuals affected by skin disorders.

Tim Wright

Tim Wright

Editor-in-Chief , Contract Pharma

Tim Wright is the editor of Contract Pharma magazine, which is a trade publication serving thousands of pharma and biopharma outsourcing professionals. He has been editor at Rodman Media since 2006. Prior to his position at Contract Pharma, he was an editor at Coatings World and Nonwovens Industry publications. Tim has a B.A. from Montclair State University in New Jersey where he studied English literature and journalism.